Timentin

Company: SmithKline Beecham
Approval Status: Approved January 1998
Treatment for: Infections in children
Areas: Immune System; Pediatrics
Possible similar drugs: Timentin

| General Information |

General Information

Timentin (disodium/clavulanate potassium) has been approved as an injectable antibiotic for use in treating a wide range of infections in children aged 3 months to 16 years. The drug was previously approved for use in adult patients.

< back to top

Timentin Drug Information

The Timentin drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.